Advanced search
Publication Cover
Journal of Psychoactive Drugs Volume 48, 2016 - Issue 5
Submit an article Journal homepage
359
Views
14
CrossRef citations to date
0
Altmetric
Articles

The Presence of New Psychoactive Substances in a Tor Network Marketplace Environment

Diana S. DolliverAssistant Professor, Department of Criminal Justice, The University of Alabama, Tuscaloosa, AL, USACorrespondence[email protected]
, Ph.D. &
Joseph B. KuhnsProfessor, Department of Criminal Justice and Criminology, University of North Carolina–Charlotte, Charlotte, NC, USA
, Ph.D.
Pages 321-329 | Received 20 May 2016, Accepted 08 Aug 2016, Published online: 23 Sep 2016

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Francois R. Lamy, Raminta Daniulaityte & Steven Dudley$suffix/text()$suffix/text(). (2024) “Pressed OXY M30 Pills, Great Press, Potent, Fast Shipping!!!”: Availability of Counterfeit and Pharmaceutical Oxycodone Pills on One Major Cryptomarket. Journal of Psychoactive Drugs 56:1, pages 1-7.
Read now
Stephen L. Thornton, Michael A. Darracq, Hallam M. Gugelmann & Patil Armenian. (2019) Surface internet marketplace presence and availability of NPS sold as research chemicals: a snapshot study. Toxicology Communications 3:1, pages 67-74.
Read now

Articles from other publishers (12)

Mahdieh Zabihimayvan, Reza Sadeghi & Derek Doran. (2024) Security, information, and structure characterization of Tor: a survey. Telecommunication Systems.
Crossref
York Yannikos, Julian Heeger & Martin Steinebach. (2022) Data Acquisition on a Large Darknet Marketplace. Data Acquisition on a Large Darknet Marketplace.
Mahdieh Zabihimayvan & Derek Doran. (2022) A first look at references from the dark to the surface web world: a case study in Tor. International Journal of Information Security 21:4, pages 739-755.
Crossref
Allyn C. Howlett, Brian F. Thomas & John W. Huffman. (2021) The Spicy Story of Cannabimimetic Indoles. Molecules 26:20, pages 6190.
Crossref
Karissa Resnik, Pedro Brandão & Emanuele Amorim Alves. (2021) DARK Classics in Chemical Neuroscience: Bucinnazine. ACS Chemical Neuroscience 12:19, pages 3527-3534.
Crossref
Francois R. Lamy, Raminta Daniulaityte, Monica J. Barratt, Usha Lokala, Amit Sheth & Robert G. Carlson. (2021) “Etazene, safer than heroin and fentanyl”: Non-fentanyl novel synthetic opioid listings on one darknet market. Drug and Alcohol Dependence 225, pages 108790.
Crossref
Francois R. Lamy, Raminta Daniulaityte, Monica J. Barratt, Usha Lokala, Amit Sheth & Robert G. Carlson. (2020) Listed for sale: Analyzing data on fentanyl, fentanyl analogs and other novel synthetic opioids on one cryptomarket. Drug and Alcohol Dependence 213, pages 108115.
Crossref
Nicole S. Jones & Jeffrey H. Comparin. (2020) Interpol review of controlled substances 2016–2019. Forensic Science International: Synergy 2, pages 608-669.
Crossref
Jakob Demant, Rasmus Munksgaard, David Décary-Hétu & Judith Aldridge. (2018) Going Local on a Global Platform. International Criminal Justice Review 28:3, pages 255-274.
Crossref
Judith Aldridge, Alex Stevens & Monica J. Barratt. (2017) Will growth in cryptomarket drug buying increase the harms of illicit drugs?. Addiction 113:5, pages 789-796.
Crossref
Juha Nurmi, Teemu Kaskela, Jussi Perälä & Atte Oksanen. (2017) Seller’s reputation and capacity on the illicit drug markets: 11-month study on the Finnish version of the Silk Road. Drug and Alcohol Dependence 178, pages 201-207.
Crossref
Andreas Kimergård, Michelle Foley, Zoe Davey, Elle Wadsworth, Colin Drummond & Paolo Deluca. (2017) The challenge of complex drug use: Associated use of codeine‐containing medicines and new psychoactive substances in a European cross‐sectional online population. Human Psychopharmacology: Clinical and Experimental 32:3.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.